We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Recession coverage

Gingival recession is extremely common and can lead to complications such as root caries, compromised esthetic appearance, reduced oral hygiene and root surface hypersensitivity.1,2

Autogenous soft tissue grafts, such as free gingival grafts or connective tissue grafts, have proven successful in covering recession defects.1 However, harvesting those grafts, usually from the palate, is painful, technically demanding, time consuming and may lead to complications such as bleeding, pain, swelling, and occasionally also numbness or infections.3-6

Geistlich Fibro-Gide® or Geistlich Mucograft® combined with a coronally advanced flap or in minimal invasive techniques represent a viable alternative to recession coverage with an autologous graft.7,8 As their use spares creating a second surgical site, collagen matrices such as Geistlich Mucograft® or Geistlich Fibro-Gide® are associated with less chair time, patient pain perception and lower patient morbidity.10-12



  1. Chambrone L, et al.: Cochrane Database Syst Rev (2): CD007161. (systematic review)
  2. Bignozzi I, et al.: J Periodontal Res. 2014; 49(2): 143-63. (review)
  3. Griffin TJ, et al.: J Periodontol 2006; 77: 2070-79. (clinical study)
  4. Soileau KM, et al.: J Periodontol 2006; 77: 1267-73. (clinical study)
  5. Zucchelli G, et al.: J Clin Periodontol 2010; 37: 728-38. (clinical study)
  6. Cairo F, et al.: J Clin Periodontol 2012; 39: 760-68. (clinical study)
  7. McGuire MK & Scheyer ET: J Periodontol 2016; 87(3): 221-7.
  8. Cardaropoli D, et al.: J Periodontol 2012; 83(3): 321-28.
  9. Griffin TJ, et al.: J Periodontol 2006; 77: 2070-79. (clinical study)
  10. Sanz M, et al.: J Clin Periodontol 2009; 36(10): 868-76. (clinical study)
  11. Geistlich Mucograft® Seal Advisory Board Meeting Report, 2013. Data on file, Geistlich Pharma AG, Wolhusen, Switzerland.
  12. Lorenzo R, et al.: Clin Oral Impl Res 2012; 23(3): 316-24. (clinical study)
Verena Vermeulen
Group Lead Clinical Marketing